{"id":616294,"date":"2026-09-30T00:42:31","date_gmt":"2026-09-30T00:42:31","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/616294\/everion-pharmaceuticals-coo-announces-30-companywide-promotion-across-expanded-research-portfolio.html"},"modified":"2026-09-30T00:42:31","modified_gmt":"2026-09-30T00:42:31","slug":"everion-pharmaceuticals-coo-announces-30-companywide-promotion-across-expanded-research-portfolio","status":"publish","type":"post","link":"https:\/\/www.pennsylvania-magazine.com\/news\/story\/616294\/everion-pharmaceuticals-coo-announces-30-companywide-promotion-across-expanded-research-portfolio.html","title":{"rendered":"Everion Pharmaceuticals COO Announces 30% Company-Wide Promotion Across Expanded Research Portfolio"},"content":{"rendered":"<div style=\"font-style:italic;padding:8px 0px\">Newly appointed COO Alina Khomenko launches promotional initiative using code GET30OFF as Everion continues expanding its research pharmaceutical platform.<\/div>\n<p style=\"text-align: justify\"><strong><img decoding=\"async\" style=\"margin-left: auto;margin-right: auto\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/09\/fe5ffe95a80fd68b688db2dee5e170e4.jpg\" alt=\"\" \/><\/strong> <em>Alina Khomenko, Chief Operating Officer, Everion Pharmaceuticals. Photo courtesy of Everion Pharmaceuticals.<\/em><\/p>\n<p style=\"text-align: justify\"><strong>UNITED STATES &#8211; September 29, 2026 &#8211;<\/strong>&nbsp;Everion Pharmaceuticals today announced a 30% promotional discount across eligible participating products in its research portfolio, introduced by the company&#8217;s newly appointed Chief Operating Officer, Alina Khomenko.<\/p>\n<p style=\"text-align: justify\">Using promotional code<strong> GET30OFF<\/strong>, eligible customers can receive 30% off participating products through EverionPharma.com for the promotional period.<\/p>\n<p style=\"text-align: justify\"><em>&#8220;Growth only matters when the people we serve benefit from it,&#8221; said Alina Khomenko, Chief Operating Officer of Everion Pharmaceuticals. &#8220;As I begin this new chapter with Everion, I want our customers and research partners to see immediately what our priorities are: accessibility, quality, transparency and continued innovation. This promotion introduces more researchers to the breadth of the expanding Everion portfolio.&#8221;<\/em><\/p>\n<p style=\"text-align: justify\"><strong>UNLOCK HUMAN POTENTIAL &#8211; 30% OFF PROMOTIONAL CODE: GET30OFF<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Expanded Research Portfolio <\/strong><\/p>\n<p style=\"text-align: justify\">Everion&#8217;s expanding portfolio includes <strong>Semaglutide, Tirzepatide, Retatrutide, BPC-157, TB-500, CJC-1295, Ipamorelin, Tesamorelin, Sermorelin, MOTS-C, GHK-Cu, NAD+, AOD-9604, 5-Amino-1MQ, Thymosin Alpha-1, DSIP, LL-37, Semax, Selank, Pinealon, Kisspeptin-10, IGF-1 LR3, HGH 191AA, PT-141, Oxytocin Acetate and Melanotan II<\/strong>, among other products in the Everion research portfolio.<\/p>\n<p style=\"text-align: justify\">Products described as research products are presented for research purposes. Product status, eligibility and promotional availability may vary.<\/p>\n<p style=\"text-align: justify\"><strong>A New Chapter for Everion<\/strong><\/p>\n<p style=\"text-align: justify\">Khomenko&#8217;s appointment comes during a period of continued development for Everion Pharmaceuticals as the company works to strengthen its international footprint and build relationships across research, pharmaceutical and wellness markets.<\/p>\n<p style=\"text-align: justify\">Her responsibilities as COO include helping oversee international operations, organizational development, strategic partnerships and the continued expansion of Everion&#8217;s global business infrastructure.<\/p>\n<p style=\"text-align: justify\">&#8220;We are building Everion for the future,&#8221; said <strong>Samier Tadros, Founder, Chairman, President &amp; CEO of Everion Pharmaceuticals<\/strong>. &#8220;Alina brings an international perspective, tremendous energy and a commitment to execution. This promotion is only the beginning of what our customers will see as we continue expanding the company.&#8221;<\/p>\n<p style=\"text-align: justify\">&#8220;Everion&#8217;s mission is captured in three words: Unlock Human Potential. My responsibility as COO is to help turn those words into action &#8211; through stronger operations, international growth and a company that never stops looking for ways to better serve the research community,&#8221; Khomenko added.<\/p>\n<p style=\"text-align: justify\"><strong>About Everion Pharmaceuticals <\/strong><\/p>\n<p style=\"text-align: justify\">Everion Pharmaceuticals is a research pharmaceutical company focused on providing research products while expanding its international operations and distribution network. The company continues to invest in product availability, quality standards, laboratory documentation, customer service and global growth.<\/p>\n<p style=\"text-align: justify\">Promotional Code: <strong>GET30OFF<\/strong><\/p>\n<p style=\"text-align: justify\">For more information visiit website:&nbsp;<a rel=\"nofollow noopener\" href=\"EverionPharma.com%20\" target=\"_blank\">EverionPharma.com <\/a>or send an email via <a rel=\"nofollow\" href=\"mailto:Kimberly.wheeler@everionpharma.com\">Kimberly.wheeler@everionpharma.com<\/a>.<\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/EverionPharma.com_195896.html\">Everion Pharmaceuticals<\/a><br \/><strong>Contact Person:<\/strong> Kimberly Wheeler <br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=everion-pharmaceuticals-coo-announces-30-companywide-promotion-across-expanded-research-portfolio\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 (754) 457-3468<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"http:\/\/EverionPharma.com\" target=\"_blank\">EverionPharma.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=everion-pharmaceuticals-coo-announces-30-companywide-promotion-across-expanded-research-portfolio\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Newly appointed COO Alina Khomenko launches promotional initiative using code GET30OFF as Everion continues expanding its research pharmaceutical platform. Alina Khomenko, Chief Operating Officer, Everion Pharmaceuticals. Photo courtesy of Everion<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/616294"}],"collection":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/comments?post=616294"}],"version-history":[{"count":0,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/616294\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/media?parent=616294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/categories?post=616294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/tags?post=616294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}